64
Participants
Start Date
July 31, 2005
Primary Completion Date
July 31, 2008
Study Completion Date
September 30, 2009
consensus interferon (Interferon Alfacon-1) and ribavirin
CIFN (15 mcg/day SQ) and RBV (1-1.2 g/d PO) given for either 52 weeks (group A, n = 33) or 52-72 weeks (from time of viral response +48 weeks) (group B)
Consensus Interferon alfa (CIFN) and ribavirin
CIFN (15 mcg/day SQ) and RBV (1-1.2 g/d PO) given for either 52 weeks (group A, n = 33) or 52-72 weeks (from time of viral response +48 weeks) (group B)
Collaborators (1)
Center for Veterans Research and Education
OTHER
InterMune
INDUSTRY
Kadmon Corporation, LLC
INDUSTRY
US Department of Veterans Affairs
FED
San Diego Veterans Healthcare System
FED
Minneapolis Veterans Affairs Medical Center
FED